Nat Turner and Zach Weinberg founded Flatiron Health in 2012 shortly after their first company was acquired by Google. A few years earlier, Nat’s seven-year old cousin Brennan was diagnosed with a rare leukemia. It was during Brennan’s cancer treatment journey when he and Zach first witnessed a fragmented and siloed healthcare system. Nat and Zach started Flatiron in pursuit of an audacious idea: combine some of the best minds in medicine and technology to transform the way cancer is understood and treated.
The experience of every cancer patient is a powerful legacy. Each patient’s story has the unique potential to teach us something new about the way cancer works, and help us find more effective treatments, faster.
At Flatiron, we believe that learning from the experience of every cancer patient is an imperative — it is the key to accelerating research and continuing to improve the quality of care. What stands in the way is an overwhelming technology challenge: much of the available, real-world clinical data is unstructured and stored across thousands of disconnected community clinics, medical centers and hospitals. It is a problem that we believe we can solve.
2.2 million active patient records available for research by Flatiron's solutions
Over 15 of the top therapeutic oncology companies work with Flatiron
280+ community oncology practices
2,600+ OncoEMR clinician users
Flatiron's OCM network includes 55 community oncology practices across 20 states
Seven major academic research centers partner with Flatiron
Headquarters in NYC, office in SF